myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig. Am J Physiol Cell Physiol 298: C1118 -C1126, 2010. First published February 17, 2010 doi:10.1152/ajpcell.00269.2009To explore the precise mechanisms of the inhibitory effects of blebbistatin, a potent inhibitor of myosin II, on smooth muscle contraction, we studied the blebbistatin effects on the mechanical properties and the structure of contractile filaments of skinned (cell membrane permeabilized) preparations from guinea pig taenia cecum. Blebbistatin at 10 M or higher suppressed Ca 2ϩ -induced tension development at any given Ca 2ϩ concentration but had little effects on the Ca 2ϩ -induced myosin light chain phosphorylation. Blebbistatin also suppressed the 10 and 2.75 mM Mg 2ϩ -induced, "myosin light chain phosphorylation-independent" tension development at more than 10 M. Furthermore, blebbistatin induced conformational change of smooth muscle myosin (SMM) and disrupted arrangement of SMM and thin filaments, resulting in inhibition of actin-SMM interaction irrespective of activation with Ca 2ϩ . In addition, blebbistatin partially inhibited Mg 2ϩ -ATPase activity of native actomyosin from guinea pig taenia cecum at around 10 M. These results suggested that blebbistatin suppressed skinned smooth muscle contraction through disruption of structure of SMM by the agent. smooth muscle; skinned preparations; contractile filaments; adenosinetriphosphatase BLEBBISTATIN WAS FOUND as an agent to inhibit cytokinesis (31) and characterized as an inhibitor of myosin II by Sellers and colleagues (15, 16). The agent strongly inhibited most vertebrate striated muscle and nonmuscle myosin II ATPase activities at around 1 M (16). Blebbistatin also suppressed the activities of myosin ATPase from vertebrate smooth muscles at around 10 M (4, 13), although the agent was less sensitive to inhibiting turkey gizzard myosin ATPase activity (16). We, along with other investigators, also have found that blebbistatin inhibited the tissue and cell smooth muscle contraction at around 10 M (4, 5, 13, 34). The inhibitory mechanisms of blebbistatin on the actin-myosin interaction have been thought to inhibit enzymatic activity of myosin heavy chain, resulting in interference of cross-bridge cycling (15, 16) . In addition, our previous study showed that blebbistatin induced distinct conformational change of chicken gizzard myosin II and heavymeromyosin (HHM) irrespective of phosphorylation of myosin regulatory light chain (MLC 20 ) at around 20 M (13). The results indicated a possibility that conformational change of smooth muscle myosin (SMM) by blebbistatin spatially interferes with actin-myosin interaction of smooth muscle cells. In the present study, we thus hypothesized that conformational change of SMM by blebbistatin would induce disruption of the arrangement and structure of contractile filaments and inhibition of the ATPase activity of SMM simultaneously, causing suppression of the smooth muscle contraction without affecting the phosphorylation level of MLC 20 . To test the hypothesis, we studied the effects of blebbistatin on the mechanical properties, phosphorylation level of MLC 20 , and structure of the contractile filaments of skinned (cell membrane permeabilized) taenia cecum from guinea pig, since myosin filament structure in intact and skinned taenia cecum was examined in detail and thought to be stable irrespective of MLC 20 phosphorylation (28, 39). Also, we examined blebbistatin effects on the ATPase activity of actomyosin from guinea pig taenia cecum. A preliminary report was submitted in abstract form (35).
BLEBBISTATIN WAS FOUND as an agent to inhibit cytokinesis (31) and characterized as an inhibitor of myosin II by Sellers and colleagues (15, 16) . The agent strongly inhibited most vertebrate striated muscle and nonmuscle myosin II ATPase activities at around 1 M (16). Blebbistatin also suppressed the activities of myosin ATPase from vertebrate smooth muscles at around 10 M (4, 13), although the agent was less sensitive to inhibiting turkey gizzard myosin ATPase activity (16) . We, along with other investigators, also have found that blebbistatin inhibited the tissue and cell smooth muscle contraction at around 10 M (4, 5, 13, 34). The inhibitory mechanisms of blebbistatin on the actin-myosin interaction have been thought to inhibit enzymatic activity of myosin heavy chain, resulting in interference of cross-bridge cycling (15, 16) . In addition, our previous study showed that blebbistatin induced distinct conformational change of chicken gizzard myosin II and heavymeromyosin (HHM) irrespective of phosphorylation of myosin regulatory light chain (MLC 20 ) at around 20 M (13). The results indicated a possibility that conformational change of smooth muscle myosin (SMM) by blebbistatin spatially interferes with actin-myosin interaction of smooth muscle cells. In the present study, we thus hypothesized that conformational change of SMM by blebbistatin would induce disruption of the arrangement and structure of contractile filaments and inhibition of the ATPase activity of SMM simultaneously, causing suppression of the smooth muscle contraction without affecting the phosphorylation level of MLC 20 . To test the hypothesis, we studied the effects of blebbistatin on the mechanical properties, phosphorylation level of MLC 20 , and structure of the contractile filaments of skinned (cell membrane permeabilized) taenia cecum from guinea pig, since myosin filament structure in intact and skinned taenia cecum was examined in detail and thought to be stable irrespective of MLC 20 phosphorylation (28, 39) . Also, we examined blebbistatin effects on the ATPase activity of actomyosin from guinea pig taenia cecum. A preliminary report was submitted in abstract form (35) .
MATERIALS AND METHODS
All experimental procedures conformed to the "Guidelines for Proper Conduct of Animal Experiments" approved by the Science Council of Japan and were carried out under the "Rules and Regulation of the Animal Studies Committee of Tokyo Medical University" and "The Principles of Animal Care and Experimental Committee of Gunma University." In addition, the institutional Animal Care and Use Committee of Tokyo Medical University and Gunma University approved all procedures involving animals. Male Hartley guinea pigs weighing from 250 to 500 g were euthanized under deep anesthesia with diethyl ether, and then the taenia cecum was removed.
Measurements of mechanical responses using skinned muscle preparations. A small muscle layer strip (100 -200 m wide and 3.0 -4.0 mm long) was attached to a pair of tungsten wires with silk thread monofilaments, one of which was connected to a force transducer (BG-10; Kulite Semiconductor Products, Leonia, NJ) to measure isometric tension (36) . To change the solution quickly, we used a bubble plate system with eight wells (0.135 ml each) (9) . An intact muscle preparation was attached to the experimental chamber and then stretched to produce a passive tension of ϳ30 N in physiological saline solution [PSS; 150 mM NaCl, 4 mM KCl, 2 mM Ca(methanesulfonate) 2, 1 mM Mg(methanesulfonate)2, 10 mM glucose, and 5 mM HEPES, and pH was adjusted with Tris to pH 7.45 at 25°C] with 50 U/ml insulin (Sigma, St. Louis, MO) to keep the preparations healthy (8, 29) . The skinning (cell membrane permeabilization) procedure has been described elsewhere (19, 27, 38) . Briefly, an intact preparation was treated with 200 M ␤-escin (Sigma) for 20 min and with 20 M Ca 2ϩ ionophore A-23187 (Sigma) for 10 min in the relaxing solution. Note that the skinning procedure using ␤-escin might not critically affect functional or structural characterization of the SMM of the preparations, since even treatment with much higher concentrations of ␤-escin did not elute large cellular molecules such as myosin heavy chain from the smooth muscle preparations (36) . To prevent serious deterioration of the skinned preparations and precipitation of blebbistatin in the solution, we maintained the experimental temperature at 30.0 Ϯ 1.0°C. The skinned preparation was stretched in a relaxing solution [115 mM K(methanesulfonate), 1.2 mM Mg(methanesulfonate) 2, 1.35 mM Na2-ATP, 20 mM creatine phosphate, and 10 mM EGTA]. After the passive tension reached a steady level (resting tension, ϳ10 N), the preparation was immersed in 10 Ϫ4. 35 M Ca 2ϩ to elicit the maximal Ca 2ϩ -induced contraction (control contraction). When the active tension increased to the maximal steady level, the preparation was relaxed by quickly lowering Ca 2ϩ concentration within the relaxing solution and then reactivated with various concentrations of Ca 2ϩ or 10 or 2.75 mM Mg 2ϩ in the absence (vehicle, 1% DMSO) or presence of blebbistatin (test contraction).
Solutions and chemicals. Artificial intracellular solutions for skinned preparations were prepared according to the method of Horiuti (9) . Solutions of various Ca 2ϩ concentrations were prepared by mixing the relaxing solution that contained 10 mM EGTA and the solution for maximal contraction that contained 10 mM EGTA and 10 mM Ca(methanesulfonate) 2 in the appropriate proportion with the addition of 1 M calmodulin (Wako Pure Chemicals, Osaka, Japan). The ionic strength was kept at 200 mM by adjusting the K(methanesulfonate) concentration, and pH was set to 7.0 with 20 mM PIPES and KOH at 30°C. All solutions contained 0.85 mM free Mg 2ϩ and 1.0 mM MgATP (8, 40) . Mg 2ϩ and MgATP concentrations were chosen based on those measured in the intact taenia cecum (20, 33) . To keep the MgATP supply sufficient, we chose concentrations of creatine phosphate (20 mM; Ref. 8) about 10 times higher than that in the intact taenia cecum preparations (20) . The apparent dissociation constant of Ca 2ϩ -EGTA was assumed to be 10 Ϫ6.4 M. The 10 and 2.75 mM Mg 2ϩ and MgCTP solutions, which were used for MLC20 phosphorylation-independent contraction, contained 10 and 2.75 mM Mg 2ϩ , respectively. Also, the solutions contained 1.0 mM MgCTP (1.4 mM total Na2CTP; Sigma), 20 mM creatine phosphate, and 10 mM EGTA (38) , since MgCTP is a poor substrate for several kinase reactions including MLC 20 phosphorylation but strongly activates myosin ATPase (2, 6) . S-(Ϫ)-blebbistatin was purchased from Toronto Research Chemicals (North York, ON, Canada) and used as an active form of blebbistatin. According to Shu et al. (30) , S-(Ϫ)-blebbistatin is a mixture of 59% (Ϫ)-enantiomer and 41% (ϩ)-enantiomer (30) . It is known that the active isomer of blebbistatin is (Ϫ)-blebbistatin, and (ϩ)-blebbistatin had no effects on ATPase activities of various types of myosin II (4, 30, 31, 34) , cell migration of cultured smooth muscles (34) , or contraction of intact smooth muscles (4) . All other chemicals were reagent grade.
Data analysis of the mechanical properties. The developed tension levels of the test contraction of skinned preparations are expressed as follows:
relative tension ϭ (observed tension of test contraction Ϫ resting tension) ⁄ (maximum tension of control contraction Ϫ resting tension).
To estimate blebbistatin concentration for the half-maximal effect of the relative tension level of the test contraction (ED 50), we carried out nonlinear least-squares fitting by a modified Hill equation with the program Kaleida Graph (Synergy Software, Reading, PA) using the Levenberg-Marquardt algorithm: concentration for half-maximal relative tension level of the test contraction activated with Ca 2ϩ . MLC20 phosphorylation. After mechanical measurements, the skinned preparations, which were still attached to the tungsten wires of the force measurement apparatus, were quickly fixed by immersion in cold trichloroacetic acid (TCA) at 10% in acetone containing 10 mM dithiothreitol (DTT) for 15 min. After the preparations were removed from the force measurement apparatus, TCA was washed out with acetone containing 10 mM DTT three times. The dried preparations were then incubated in a urea sample buffer (containing 20 mM Trizma base, 10 mM DTT, 8 M urea, and 0.1% bromophenol blue) for 8 h at 4°C. The extracts were subjected to glycerol-PAGE coupled with Western blotting (13, 26) . MLC 20 was detected with anti-MLC20 antibody made by S. Yoshiyama and visualized with horseradish peroxidase-conjugated anti-rabbit IgG (GE Healthcare, Little Chalfont, UK) and an enhanced chemiluminescence Western blotting detection system (ECL; GE Healthcare). The contents of mono-and diphosphorylated MLC 20 were quantitatively measured using a densitometer (Lumi-Imager F1; Roche Diagnostics, Mannheim, Germany). The phosphorylation level of MLC20 was calculated as follows:
where T and U are densities of total and unphosphorylated MLC20, respectively.
Immunofluorescence microscopic observation. After mechanical measurements were made, the skinned preparations were quickly frozen with liquid nitrogen. Longitudinal sections (2 m thick) of the preparations were cut with a cryostat microtome (CR-502; Yamato Kohki Industrial, Saitama, Japan) and placed on poly-L-lysine-coated glass slides. These sections were fixed with 1.5% paraformaldehyde in phosphate-buffered saline (PBS; 9.54 mM, pH 7.3) and washed with PBS before immunostaining. The sections were incubated with a blocking solution of 5% bovine serum albumin (BSA) in PBS for 1 h and then reacted with anti-SMM antibody (Sigma) for 3 h at 4°C. After being washed with 1% BSA in PBS three times, the anti-SMM antibody and F-actin of the sections were labeled with donkey antimouse IgG-conjugated rhodamine red-X (Jackson ImmunoResearch, West Grove, PA) and FITC-phalloidin (Invitrogen, Carlsbad, CA) for 3 h at 4°C, respectively. After labeling, the sections were washed three times and then mounted with 90% glycerol in PBS containing 5% 1,4-diazabicyclo[2.2.]-octane as an antiquenching agent. The sections were observed with a Bio-Rad MRC-1024 confocal microscope (BioRad Laboratories, Richmond, CA) and recorded with computer software (Confocal Assistant 4.02, written by Todd Clark Brelje). A montage of images for the sections with different labeling was done using Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA). Nonspecific reactions were not detected in any control preparations.
Fluorescence resonance energy transfer analysis by confocal microscopy. Antibody-based fluorescence resonance energy transfer (FRET) analysis was used to measure the interaction between F-actin and SMM in the skinned taenia cecum preparations (14, 34) . Fixed longitudinal sections (2 m thick) of skinned preparations that had been used for mechanical measurements were labeled with primary antibody and FITC(488)-phalloidin (fluorescein; Invitrogen) targeted to SMM and F-actin, respectively, and then treated with fluorescent probe Alexa 546 IgG (Invitrogen) secondary antibody to designate F-actin (donor) and SMM (acceptor) as the components of the FRET system. Initially, F-actin was imaged with a 522DF32 band-pass filter at 3% laser power. The acceptor, SMM, was photobleached with 100% laser power using the 568-nm laser line for 45-60 min until the signal was lost. A second image was recorded using the same donor setting to evaluate protein interaction. Cell pixel intensity data were collected using ImageJ software and analyzed with PeakFit software version 4.11 (SPSS Science, Chicago, IL) for the before and after photobleaching image. Paint Shop Pro software version 7.0 (Corel, Ottawa, ON, Canada) was used to show the difference between before and after photobleaching (FRET response). Relative increases in fluorescence for vehicle-or blebbistatin-treated preparations were presented as indexes of the FRET responses.
Electron microscopic observation. After mechanical measurements were made, the skinned preparations were prefixed with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) for 5 min at 4 -10°C, and then the preparations were removed from the force measurement apparatus and immersed in the same solution at 4°C for 5 min. After being washed with 10% sucrose in cacodylate buffer (pH 7.3), the preparations were postfixed with 10% sucrose and 1% OsO4 in the cacodylate buffer (pH 7.3) for 2 h at 4°C. The preparations were then stained with 0.5% aqueous uranyl acetate and Epon 812 (Nisshin, Tokyo, Japan). Thin sections (ϳ100 nm thick) of the stained preparations were cut with a diamond knife (Micro Star Technologies, Huntsville, TX) and further stained with 0.5% uranyl acetate and 0.4% lead citrate. Finally, the stained preparations were observed with an electron microscope (JEM-1010; JEOL, Tokyo, Japan). To measure the size of the dot-like structures, we used the image analysis software Scion Imaging (Scion, Frederick, MD).
Immunoelectron microscopy. Analysis of immunoelectron microscopic images was carried out using the methods described by Tanaka et al. (32) . Briefly, the skinned preparations that had been used for mechanical measurements were fixed with 2% paraformaldehyde and then frozen with liquid nitrogen. Sections of the fixed preparations were cut and placed on acrylamide-coated glass slides. After incubation in PBS with 5% BSA for 3 h at 4°C, the sections on the glass slides were reacted with anti-SMM antibody (Sigma) as the primary antibody and then incubated with secondary antibody conjugated with 6-nm gold particles (Jackson ImmunoResearch). The immunogoldstained sections on acrylamide sheets were peeled from the glass slides and then processed for electron microscopic observation.
Measurement of Mg 2ϩ -ATPase activity of native actomyosin from guinea pig taenia cecum. A Ca 2ϩ -sensitive native actomyosin (myosin B) preparation, which contained a calmodulin-myosin light chain kinase and phosphatase system, was prepared from guinea pig taenia cecum in accordance with Ozaki et al. (21) . Briefly, intact taenia cecum (ϳ500 g) was homogenized and blended with four volumes of solution containing 400 mM KCl, 20 mM Tris·HCl (pH 7.5), 5 mM ATP, and 0.1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (p-ABSF; Wako) to inhibit protease activities. The material was centrifuged at 10,000 g for 5 min. ATP (10 mM) was added to the supernatant solution, which was recentrifuged at 80,000 g for 30 min. The supernatant was then dialyzed against a ninefold solution containing 1 mM NaHCO3, 1 mM MgCl2, 1 mM NaN3, 1 mg/ml DTT, and 0.1 mM p-ABSF for 4 h. Dialyzed material was centrifuged at 10,000 g for 5 min. Native actomyosin preparation was obtained after being washed two times in 50 mM KCl, 1 mM MgCl 2, and 1 mM NaHCO3. The Mg 2ϩ -ATPase reaction of native actomyosin was carried out at 30°C in a medium containing 1 mg protein/ml actomyosin, 50 mM KCl, 10 mM MgCl2, 20 mM Tris-maleate (pH 6.8), and Ca 2ϩ -EGTA buffer for 3 min. Inorganic phosphate liberated during a 3-, 5-, or 10-min incubation was determined with the EnzChek phosphate assay kit (Invitrogen). Blebbistatin concentration for the half-maximal effect on actomyosin ATPase activity was estimated by data-fitting analysis to the modified Hill equation described above.
Statistical analysis. Results are means Ϯ SE. Statistical hypotheses on the differences between means were tested with Student's t-test for paired samples or one-way ANOVA with post hoc analysis using Kaleida Graph 3.6J. The null hypotheses were rejected when P was Ͻ0.05.
RESULTS

Effects of blebbistatin on the Ca
2ϩ -induced contraction of skinned preparations. Figure 1A presents typical tension records of the ␤-escin skinned preparations of taenia cecum from guinea pig. When a smooth muscle preparation was activated with 2 M Ca 2ϩ and 1 M calmodulin, the active tension quickly developed and reached a sustained level within 2 min. In the presence of blebbistatin at a concentration of 10 M or higher, the active tension development was irreversibly suppressed. On the other hand, blebbistatin did not affect the resting (passive) tension at all, even when treated at 100 M (data not shown). Therefore, blebbistatin seemed to interfere with the actin-myosin interaction of the contractile filaments, rather than changing the function and/or structure of the cytoskeleton and the other elastic components of the skinned taenia cecum. Blebbistatin at 10 M or higher also suppressed the active tension when the agent was applied after the developed force reached the sustained level (data not shown). Figure 1B shows the blebbistatin effects on the relationship between Ca 2ϩ concentration and the active tension. (12, 18) . As shown in Fig. 2A , 10 mM Mg 2ϩ with 1.0 mM MgCTP induced an increase in the tension with a short time lag (ϳ45 s). On the other hand, 10 mM Mg 2ϩ did not induce phosphorylation of MLC 20 at all, irrespective of blebbistatin (data not shown). Blebbistatin significantly suppressed the 10 mM Mg 2ϩ -induced tension development at concentrations higher than 10 M (Fig. 2B) , and the estimated ED 50 for the relative force inhibition was 12.5 M (Fig. 2B) . Blebbistatin did not affect the short time lag (Fig. 3A) . Blebbistatin at 30 M also significantly suppressed very slow tension development induced by much lower concentrations of Mg 2ϩ (Fig. 4) , indicating that the agent suppressed not only the steady-state cross-bridge cycling but also the initial rate of the force development.
Effects of blebbistatin on the myofilament localization of skinned taenia cecum. Since several myosin II inhibitors, such as 2,3-butanedione monoximine (BDM) or N-benzyl-N-nitroso-p-toluenesulfonamide (BTS), disrupt the organization and filamentous structure of myosin and actin in the striated myotube (10, 23), we examined the effects of blebbistatin on the localization of contractile filaments of skinned smooth muscle preparations of taenia cecum (Fig. 4) . In the control experiments, F-actin and anti-SMM antibody labeled with anti-mouse IgG conjugated with rhodamine red-X and FITCphalloidin, respectively, were almost entirely colocalized when the preparation was activated with Ca 2ϩ (Fig. 4F) . On the other hand, in the presence of 30 M blebbistatin, F-actin and anti-SMM antibody were only partially colocalized even when activated with Ca 2ϩ (Fig. 4L) . These results indicate that, in the presence of 30 M blebbistatin at which Ca 2ϩ -activated contraction was maximally inhibited, most of the SMM and F-actin in the skinned taenia cecum were separately localized even when activated with Ca 2ϩ . Note that neither nonmuscle myosin IIA (NMM-A) nor IIB (NMM-B) was detected by immunostaining irrespective of Ca 2ϩ (data not shown). 
FRET analysis of association of F-actin and smooth musclemyosin.
To determine whether actin-SMM interaction in skinned smooth muscles was really interfered with by blebbistatin treatment, we analyzed confocal images of immunohistochemically stained skinned taenia cecum using FRET (14, 34) , which showed a clear increment of fluorescent intensity of F-actin after photobleaching of SMM only when the SMM interacted with the F-actin (Fig. 5) . FRET, on average, showed that contracted preparations increased F-actin fluorescence (175.7 Ϯ 2.1%). By comparison, FRET values of relaxed, relaxed and blebbistatin-treated, and Ca 2ϩ -activated and blebbistatin-treated preparations were 110.9 Ϯ 1.2, 106.0 Ϯ 0.9, and 106.0 Ϯ 0.9%, respectively. Statistical analysis performed using Dunn's procedure for multiple comparison showed that the average responses of these three conditions were significantly lower than that of the Ca 2ϩ -activated condition (P Ͻ 0.0001, n ϭ 10), but there were no significant differences among the three conditions (P Ͼ 0.09). These results suggest that the interaction of actin and SMM by Ca 2ϩ -induced activation was clearly interfered with by the blebbistatin treatment.
Effects of blebbistatin on the filamentous structure of skinned taenia cecum preparations. We also examined the blebbistatin effects on the filamentous structure and organization of the contractile filaments of skinned taenia cecum. Figure 6 shows typical electron microscopic images of longitudinal section of the skinned taenia cecum. There are dot-like structures and filamentous structures in the images. Immunogold particles conjugated with anti-SMM bound to dot-like structures (Fig.  6F) , suggesting that most of the dot-like structures were heads of SMM. On the other hand, the filamentous structures seemed to be thin filaments because of their size. In the resting states, the orientation of the dots and thin filaments was not so regular (Fig. 6A) . During contraction, the dots and the thin filaments orientated regularly compared with those in the resting states (Fig. 6C) . However, in the presence of blebbistatin at 30 M, the orientation of the thin filaments and the dots was still irregular even during activation (Fig. 6D) . In addition, the dot size of the skinned preparations treated with 30 M blebbistatin was significantly larger than that of those treated with vehicle (1% DMSO) irrespective of Ca 2ϩ (Fig. 7) . Figure 8 shows a relationship between blebbistatin concentrations and relative Mg 2ϩ -ATPase activity of native actomyosin from taenia cecum. Blebbistatin partially inhibited actomyosin ATPase activity in the presence of 20 M Ca 2ϩ , and the estimated ED 50 value for the inhibition by blebbistatin was (B and D) , the skinned preparations were fixed with paraformaldehyde and glutaraldehyde, then fixed with sucrose and OsO4, and finally stained with uranyl acetate. Each scale bar indicates 100 nm. E: magnified image of area enclosed in a rectangle in C. F: magnified immunoelectron microscopic image of skinned taenia cecum. Sections of the fixed skinned preparations were reacted with primary antibody of anti-SMM and then incubated with secondary antibody conjugated with 6-nm gold particles. The scale of the image in F is the same as that in E. Fig. 7 . Effects of blebbistatin on the size of the dot-like structures. Size (nm 2 ) of the dot-like structures for the electron microscopic images of the skinned preparations in the presence or absence of Ca 2ϩ was measured using Scion Imaging software. Values are means Ϯ SE of 250 dots. **P Ͻ 0.05, significant difference of size among all conditions. For 1-way ANOVA, P was Ͻ0.0001.
Effects of blebbistatin on the actomyosin ATPase activity.
18.3 Ϯ 9.1 M (Fig. 8) . Changing the reaction time (3, 5, and 10 min) did not affect blebbistatin effects on the relative ATPase activities of native actomyosin (data not shown).
DISCUSSION
The present study clearly showed that in taenia cecum from guinea pig, blebbistatin at a concentration of ϳ10 M partially inhibited active tension development, changed SMM structure, and disrupted organization of the contractile filaments and actin-SMM interaction of skinned preparations without decreasing the phosphorylation level of MLC 20 . Blebbistatin also suppressed Mg 2ϩ -ATPase activity of native actomyosin (Fig. 8) . Before discussing mechanisms of the inhibitory action of blebbistatin on the smooth muscle contraction, we must note susceptibility of the blebbistatin effects on the smooth muscle contractile activities, because the agent effects on the myosin ATPase activities and active force of smooth muscle tissues have been studied by several groups, and large differences of blebbistatin effects among the studies have been discussed (4, 5, 24) . Our previous study found that the IC 50 of blebbistatin for ATPase activity of smooth muscle myosin II from bovine stomach smooth muscle was much lower than that from chicken gizzard. The blebbistatin effects on SMM seem to be highly dependent on the animal species (34) . Similar ED 50 values of blebbistatin for actomyosin ATPase activity (Fig. 8) and contraction of skinned preparations (Figs. 1 and 2 ) support the idea that animal and/or tissue species and type of smooth muscle cells are the major determinants of the sensitivity for blebbistatin effects on the smooth muscle contractile function, and the differences in the manipulation for making preparations among native actomyosin and skinned muscle do not essentially affect the sensitivity for blebbistatin on smooth muscle.
The inhibitory mechanisms of the blebbistatin on the actinmyosin interaction have been thought to inhibit enzymatic activity of myosin heavy chain, resulting in interference of cross-bridge cycling (15, 16) . In addition, in the present study, we found that blebbistatin separated localization of SMM and F-actin (Fig. 4) and also disrupted filamentous organization of the skinned preparations (Fig. 6) . Organization of the dot-like structures of electron microscopic images was disrupted by blebbistatin treatment, and also the size of each of the dots was clearly enlarged in the presence of the agent (Figs. 6 and 7) . Since immunogold particles conjugated with anti-SMM were well bound to the dots (Fig. 6A) , we conclude that the dot-like structures observed in the electron microscopic images were heads of SMM. Since the SMM of taenia cecum from guinea pig exists in filamentous polymers even in the resting states (7, 37, 39) , the dot-like structures are thought to be SMM heads of the thick filaments. Therefore, we conclude that Ca 2ϩ -induced activation of the skinned preparations arranged the SMM heads of the thick filaments more regularly and that blebbistatin disrupted thick filament arrangement (Fig. 6) . Furthermore, the present observation that blebbistatin treatment induced enlargement in the size of the dots (Fig. 7) is consistent with our previous finding (34) . Therefore, blebbistatin-induced force suppression of skinned taenia cecum seemed to at least partially arise from the spatial separation of the thick and thin filaments by the disruption of the organization of the contractile filaments (Figs. 4 and 6) . In fact, analysis of FRET by immunohistochemistry of stained preparations indicated that interaction of F-actin and SMM during activation with Ca 2ϩ was clearly inhibited by treatment with blebbistatin (Fig. 5) .
There are several possible mechanisms for disruption of the thick filaments' organization of skinned taenia cecum by blebbistatin. Generally, stabilization of SMM filaments is correlated to the phosphorylation level of MLC 20 (28) . Although the thick filaments abundantly exist in living and skinned smooth muscle cells even in the resting states (7, 37, 39) , further formation of the thick filaments in the intact and skinned preparations during activation was observed in several types of smooth muscle, such as porcine and canine trachea and rat anococcygeus (7, 28, 37, 39) . In fact, Qi et al. (22) showed that MLC 20 phosphorylation at least partially regulated the thick filament formation in living smooth muscles. However, blebbistatin-induced disruption of the thick filament arrangement in skinned taenia cecum (Fig. 6 ) seemed to be independent of MLC 20 phosphorylation/dephosphorylation, since blebbistatin had no significant effects on MLC 20 phosphorylation level at any concentration of Ca 2ϩ (data not shown). Another possibility is that changes in kinetics of ATP binding and/or releasing of its hydrolyzing substances in SMM by blebbistatin induced disruption of the thick filament organization. When MLC 20 is unphosphorylated, ATP binding to purified SMM is known to lead to changes in SMM conformation from the tail-extended 6S form to the tail-folded 10S form. Folded-tail 10S SMM traps ADP and inorganic phosphate, whereas straight-tail 6S SMM monomers, which assemble SMM filaments easily, releases these products (3). Therefore, ATP binding and release of ADP and inorganic phosphate in SMM is closely related to the conformation of the SMM molecule. Interestingly, blebbistatin specifically binds to the ATP binding region of myosin II heads and blocks the release of inorganic phosphate from the myosin heads; hence, it inhibits force generation of striated muscles (15) . Furthermore, our previous study presented that blebbistatin induced conformational changes in the myosin heads structure of purified chicken gizzard irrespective of MLC 20 phosphorylation (34). In fact, the present study showed that blebbistatin significantly increased the size of the dot-like structure irrespective of Ca 2ϩ concentration (Figs. 6 and 7) . Since conformational change of the myosin head by blebbistatin is thought not to enlarge the size of the myosin head itself (34) , in skinned taenia cecum, blebbistatin might bend myosin molecules as observed in vitro ( Fig. 6; Ref. 34 ) or induce similar conformational changes of the myosin molecules. Therefore, blebbistatin-induced disruption of the arrangement of the thick filaments of skinned taenia cecum preparations (Figs. 4 and 6 ) seems to result from SMM bending or similar conformational changes of the SMM molecules.
Interestingly, the maximal inhibitory effects of blebbistatin treatment on the active force of skinned preparations and the Mg 2ϩ -ATPase activity of native actomyosin was much smaller than those on the Mg 2ϩ -ATPase activity of purified smooth muscle (34) . Also, in the absence of actin, blebbistatin effects on the myosin ATPase activity were much more potent than those in the presence of actin ( Fig. 4 ; Ref. 34) . Actin filaments and their binding proteins, such as caldesmon, are known to have stabilizing effects on the myosin filaments in vitro (1, 11, 17) . Thus the inhibitory effects of blebbistatin on the mechanical force of the skinned preparations and also actomyosin ATPase activity are at least partially due to the disturbance of the thick filament organization as discussed above; it is therefore likely that the thin filaments interfered with the disruption of the thick filaments' organization of skinned preparations by blebbistatin treatment, resulting in relatively less potent effects of the agent on the mechanical activity of the skinned preparations.
Blebbistatin disrupted not only the arrangement of myosin heads but also the thin filament organization both in the resting states and during Ca 2ϩ activation (Fig. 6 ). Earlier reports using the striated myotube indicated that BTS-and BDM-induced disruption of the thick and thin filament organization during myogenesis was due to a failure of cross-bridge cycling (10, 23) , since BDM and BTS are thought to have little effect on the thin filaments directly. However, in the present study, disruption of the thin filament orientation was still observed even in the resting states in which actin and myosin should not interact strongly, suggesting that mechanisms other than interference with cross-bridge cycling concerned the blebbistatin-induced disruption of the thin filament organization. Because blebbistatin, as well as BDM and BTS, might have little effect on thin filaments, it is possible that some regulatory proteins (e.g., caldesmon, calponin, and myosin light chain kinase), which can bind with both actin and myosin in the physiological conditions, transmit mechanical and/or chemical information of disruption of the myosin filament structure induced by blebbistatin into the thin filaments. Further studies are necessary to explore precise mechanisms of disruption of the thin filament organization by blebbistatin treatment.
In conclusion, in skinned smooth muscles of taenia cecum, blebbistatin simultaneously inhibited F-actin-SMM interaction, force development, and organization of contractile filaments. Since remodeling of contractile filaments is thought to be a key regulatory mechanism of smooth muscle contraction (28) , blebbistatin may be a useful tool to understand smooth muscle contractile mechanisms.
